Bone marrow transplant is a complex procedure with significant risks. My passion is to make it so safe that anyone could have a successful transplant.
Where I see patients (3)
Selected research
-
A Randomized Clinical Trial Evaluating Lactiplantibacillus Plantarum for the Prevention of GI aGvHD: A Report From the Children's Oncology Group (ACCL1633).
Transplantation and cellular therapy
-
High Melphalan Exposure Increases the Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.
Transplantation and cellular therapy
-
Integrating Pulmonary and Systemic Transcriptomic Profiles to Characterize Lung Injury after Pediatric Hematopoietic Stem Cell Transplant.
medRxiv : the preprint server for health sciences
Clinical trials
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
The cumulative incidence of Grade III-IV acute GVHD at Day 100 will be summarized by incidence curves. GVHD evaluations will be performed using standard criteria.37 Patients with graft rejection will be censored.
Recruiting
More about this studyConditioning SCID Infants Diagnosed Early
Humoral immune reconstitution by 2 years post HCT, defined by specific antibody response to tetanus toxoid. Criteria for evaluation of humoral immune response are the following: - Donor T cell chimerism ≥50% - B cell count...
Recruiting
More about this studyEBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV Infection
Patients will be monitored for adverse events related to the infusion of EBV CTLs
Recruiting
More about this studyA Phase 2a Study of IV BCV in Subjects With Adenovirus Infection
Safety will be evaluated based on incidence and severity of Adverse Events, Serious Adverse Events and laboratory assessments.
Recruiting
More about this studyContact me
Learning never stops
Our classroom and bedside classes help kids get credit and keep learning during treatment.
See our school program